Due to the above-mentioned insulin sensitizing and anti-inflammatory activity of adiponectin, its plasma levels are decreased in patients with NAFLD and are associated with fat content [62]. Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.